2seventy bio (NASDAQ:TSVT) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 101.23 percent increase over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $22.94 million which beat the analyst consensus estimate of $13.96 million by 64.28 percent. This is a 84.46 percent increase over sales of $12.44 million the same period last year.